Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze G stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate G investment potential.

What is G stock price today?

Get real-time G stock price, historical data, and price charts on Financhill. Track G performance with our advanced analysis tools.

Is G a good investment?

Evaluate G investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

To buy G stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of G?

View detailed market capitalization data and company valuation metrics for G on our comprehensive analysis page.

What is the P/E ratio of G?

Use our fundamental analysis tools to view G P/E ratio and compare valuation metrics with industry peers.

View G earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Genpact Ltd. 10K Form

Buy

G
Genpact Ltd.

Last Price:

$47.90

Seasonality Move:

1.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09	10Q	G/Genpact Ltd. Quarterly
2023-08-09	10Q	G/Genpact Ltd. Quarterly
2023-05-10	10Q	G/Genpact Ltd. Quarterly
2022-11-09	10Q	G/Genpact Ltd. Quarterly
2022-08-09	10Q	G/Genpact Ltd. Quarterly
2022-05-10	10Q	G/Genpact Ltd. Quarterly

Receive G News And Ratings

See the #1 stock for the next 7 days that we like better than G

G Financial Statistics

Sales & Book Value

Annual Sales:	$4.8B
Cash Flow:	$288.9M
Price / Cash Flow:	13.25
Annual Sales:	$14.76
Price / Book:	3.25

Profitability

EPS (TTM):	3.10300
Net Income (TTM):	$551.3M
Gross Margin:	$1.7B
Return on Equity:	22.29%
Return on Assets:	10.65%

Genpact Ltd. Earnings Forecast

Key Genpact Ltd. Financial Ratios

The Gross Profit Margin over the past 23 years for G is 34.73%.
The Selling, General & Administrative Expenses for G have been equal to 20.30% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 15.74% of Operating Income.
The Net Earning history of G is 10.78% of Total Revenues.
Per Share Earnings over the last 23 years have been positive in 14 years.

Genpact Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Professional Services
Sector:	Industrials
Current Symbol:	G
CUSIP:	G3922B
Website:	genpact.com

Debt

Debt-to-Equity Ratio:	0.56
Current Ratio:	1.51
Quick Ratio:	1.43

Price-to-Earnings

Trailing P/E Ratio:	16.83
Forward P/E Ratio:	12.13

G Technical Analysis vs Fundamental Analysis

Buy

Genpact Ltd. (G) is a Buy

Is Genpact Ltd. a Buy or a Sell?

Genpact Ltd. stock is rated a Buy

The current Genpact Ltd. [G] share price is $47.91. The Score for G is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.